Evidence map›Paper›PMID 32159107›Full record

ArticleCJC open2019

An Update on the Development and Feasibility Assessment of Canadian Quality Indicators for Atrial Fibrillation and Atrial Flutter.

Roopinder K Sandhu, Stephen B Wilton, Jennifer Cruz, Clare L Aztema, Kendra MacFarlane, Robert McKelvie, Laurie Lambert, Kathy Rush, Rodney Zimmerman, Garth Oakes and 4 more

Erratum issuedAbstract read
In one paragraph

Article in CJC open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Roopinder K SandhuDepartment of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
Stephen B WiltonDepartment of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
Jennifer CruzCardiac Arrhythmia Service, St Michael's Hospital, Toronto, Ontario, Canada.
Clare L AztemaDepartment of Emergency Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Kendra MacFarlaneCanadian Cardiovascular Society, Ottawa, Ontario, Canada.
Robert McKelvieDepartment of Medicine, Population Health Research Institute, McMaster University, London, Ontario, Canada.
Laurie LambertInstitut national d'excellence en santé et en services sociaux, Montreal, Quebec, Canada.
Kathy RushFaculty of Health and Social Development ART, School of Nursing, University of British Columbia, Kelowna, British Columbia, Canada.
Rodney ZimmermanRegina General Hospital, Regina, Saskatchewan, Canada.
Garth OakesCorHealth Ontario, Toronto, Ontario, Canada.
Mark DeyellDepartment of Medicine, Division of Cardiology, University of British Columbia, British Columbia, Canada.
D George WyseDepartment of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada.
Jafna L CoxDepartments of Medicine and of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
Allan SkanesDepartment of Medicine, London Heart Institute, University of Western Ontario, London, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2010, the Canadian Cardiovascular Society Atrial Fibrillation/Atrial Flutter (AF/AFL) quality indicator (QI) working group was established to develop QIs and assess feasibility of measurement. After extensive review, 3 priority QIs were selected. However, none were measurable at a national level.

methodsThe working group reconvened in 2017 to review the relevance of previously proposed QIs, identify opportunities to develop new QIs, and propose an initial strategy for measuring and reporting.

resultsTwo additional priority QIs were added to the previous 3: proportion of patients with nonvalvular (NV) AF/AFL sorted by stroke risk stratum and annual rate of hospitalization for a new heart failure diagnosis. An environmental scan was undertaken to determine the potential of existing databases to provide national and provincial estimates. On the basis of validated administrative codes, the Canadian Institute for Health Information discharge abstract database can be used for inpatients. In collaboration with the Canadian Primary Care Sentinel Surveillance Network, 2 of the 5 QIs can be assessed in outpatients (patients with NVAF/AFL sorted by stroke risk stratum and high risk for stroke NVAF/AFL receiving oral anticoagulation). Stroke prevention therapy can be further measured in selected provinces with linked databases including prescriptions.

conclusionsThis first step could provide a better initial understanding of the quality of AF/AFL care in Canada, but important gaps in the meaningful measurement of QIs remain. The AF/AFL QI working group has limited capacity to make progress without national level leadership and the resources to support data aggregation, data analysis, and pan-Canadian reporting.

Identifiers

PMID32159107
PMCPMC7063642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.